Xiaolin Yu, Sharad Ghamande, Haitao Liu, Lu Xue, Shuhua Zhao, Wenxi Tan, . . . Hong Yan Liu. (2018). Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer. Elsevier.
Chicago Style (17th ed.) CitationXiaolin Yu, et al. Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity Against HER2+ Breast Cancer. Elsevier, 2018.
MLA (9th ed.) CitationXiaolin Yu, et al. Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity Against HER2+ Breast Cancer. Elsevier, 2018.
Warning: These citations may not always be 100% accurate.